Current Drug Therapy

Aldosterone receptor antagonists for heart failure: Current status, future indications

Author and Disclosure Information

ABSTRACTMany patients with heart failure should receive an aldosterone receptor antagonist, ie, either spironolactone (Aldactone) or the newer agent eplerenone (Inspra)—in addition to an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) or both, and a beta-blocker. We review the evidence and indications.


 

Next Article: